Search

Search Constraints

You searched for: Author/Creator Potashman, Michele

Search Results

1. [O5–03–01]: PREDICTING THE HEALTH ECONOMIC IMPACT OF EARLY TREATMENT IN PRE‐DEMENTIA ALZHEIMER's DISEASE. (1st July 2017)

2. Corrigendum to "Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling" [Bioorg. Med. Chem. 24 (2016) 2215–2234]. Issue 13 (1st July 2016)

3. Evaluation of what matters most in existing clinical outcomes assessments in Alzheimer's disease: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020)

4. Health economic modeling for Alzheimer's disease: Expert perspectives. Issue 1 (26th October 2022)

6. Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling. Issue 10 (15th May 2016)

7. Quantifying what matters most to patients and care partners in Alzheimer's disease: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020)

8. The importance of care partner input in Alzheimer's disease (AD) drug development: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020)